fda warning letters glp-1 november 2025 compounding enforcement The has issued to multiple companies marketing Letter to Fox Corporation regarding

MNT had the opportunity to speak with Laurie Glasser, MD, a physical medicine and rehabilitation physician at Hackensack Meridian Healths Jersey Shore University Medical Center in New Jersey, as to why GLP-1 use might be linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity

Coverage varies substantially between plans

"Vitamin B 12 / Pathophysiology Text"

Clinical guidance generally targets 1.22.0 g of protein per kg of body weight per day for GLP-1 users, so they can preserve lean muscle mass along their weight loss journey

Our online questionnaire evaluates your medical history, current symptoms, and weight management goals

Because Blood in Stool ICD 10 documentation acts as a roadmap for auditors, ensuring the anatomic source matches the code chapter is non-negotiable for 2026 compliance